129 related articles for article (PubMed ID: 18664332)
1. Redispersible, dry emulsion of lovastatin protects against intestinal metabolism and improves bioavailability.
Ge Z; Zhang XX; Gan L; Gan Y
Acta Pharmacol Sin; 2008 Aug; 29(8):990-7. PubMed ID: 18664332
[TBL] [Abstract][Full Text] [Related]
2. Improvement of bioavailability and photostability of amlodipine using redispersible dry emulsion.
Jang DJ; Jeong EJ; Lee HM; Kim BC; Lim SJ; Kim CK
Eur J Pharm Sci; 2006 Aug; 28(5):405-11. PubMed ID: 16777390
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization and in vitro intestinal absorption of a dry emulsion formulation containing atorvastatin calcium.
Yin YM; Cui FD; Kim JS; Choi MK; Choi BC; Chung SJ; Shim CK; Kim DD
Drug Deliv; 2009 Jan; 16(1):30-6. PubMed ID: 19555306
[TBL] [Abstract][Full Text] [Related]
4. Novel extended-release formulation of lovastatin by one-step melt granulation: in vitro and in vivo evaluation.
Ochoa L; Igartua M; Hernández RM; Gascón AR; Solinis MA; Pedraz JL
Eur J Pharm Biopharm; 2011 Feb; 77(2):306-12. PubMed ID: 21172434
[TBL] [Abstract][Full Text] [Related]
5. Enhanced oral bioavailability and antiasthmatic efficacy of curcumin using redispersible dry emulsion.
Jang DJ; Kim ST; Oh E; Lee K
Biomed Mater Eng; 2014; 24(1):917-30. PubMed ID: 24211980
[TBL] [Abstract][Full Text] [Related]
6. Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation.
Han SF; Yao TT; Zhang XX; Gan L; Zhu C; Yu HZ; Gan Y
Int J Pharm; 2009 Sep; 379(1):18-24. PubMed ID: 19508887
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process.
Kim JS; Kim MS; Park HJ; Jin SJ; Lee S; Hwang SJ
Int J Pharm; 2008 Jul; 359(1-2):211-9. PubMed ID: 18501538
[TBL] [Abstract][Full Text] [Related]
8. Distribution of lovastatin to bone and its effect on bone turnover in rats.
Jadhav SB; Narayana Murthy PS; Singh MM; Jain GK
J Pharm Pharmacol; 2006 Nov; 58(11):1451-8. PubMed ID: 17132207
[TBL] [Abstract][Full Text] [Related]
9. Improvement of oral bioavailability of lovastatin by using nanostructured lipid carriers.
Zhou J; Zhou D
Drug Des Devel Ther; 2015; 9():5269-75. PubMed ID: 26425076
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of oral bioavailability of atorvastatin calcium by self-emulsifying drug delivery systems (SEDDS).
Kadu PJ; Kushare SS; Thacker DD; Gattani SG
Pharm Dev Technol; 2011 Feb; 16(1):65-74. PubMed ID: 20088679
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical and pharmacokinetic characterization of water-soluble Coenzyme Q(10) formulations.
Hatanaka J; Kimura Y; Lai-Fu Z; Onoue S; Yamada S
Int J Pharm; 2008 Nov; 363(1-2):112-7. PubMed ID: 18706989
[TBL] [Abstract][Full Text] [Related]
12. Esterase inhibition attribute of grapefruit juice leading to a new drug interaction.
Li P; Callery PS; Gan LS; Balani SK
Drug Metab Dispos; 2007 Jul; 35(7):1023-31. PubMed ID: 17392396
[TBL] [Abstract][Full Text] [Related]
13. Effects of bile salts on the lovastatin pharmacokinetics following oral administration to rats.
Kim K; Yoon I; Chun I; Lee N; Kim T; Gwak HS
Drug Deliv; 2011 Jan; 18(1):79-83. PubMed ID: 20809680
[TBL] [Abstract][Full Text] [Related]
14. Synergistic role of self-emulsifying lipids and nanostructured porous silica particles in optimizing the oral delivery of lovastatin.
Rao S; Tan A; Boyd BJ; Prestidge CA
Nanomedicine (Lond); 2014 Dec; 9(18):2745-59. PubMed ID: 24938439
[TBL] [Abstract][Full Text] [Related]
15. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs.
Simovic S; Heard P; Hui H; Song Y; Peddie F; Davey AK; Lewis A; Rades T; Prestidge CA
Mol Pharm; 2009; 6(3):861-72. PubMed ID: 19358600
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of bioavailability of ketoprofen using dry elixir as a novel dosage form.
Ahn HJ; Kim KM; Kim CK
Drug Dev Ind Pharm; 1998 Jul; 24(7):697-701. PubMed ID: 9876518
[TBL] [Abstract][Full Text] [Related]
17. Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs.
Tan A; Simovic S; Davey AK; Rades T; Prestidge CA
J Control Release; 2009 Feb; 134(1):62-70. PubMed ID: 19013488
[TBL] [Abstract][Full Text] [Related]
18. Formulation design and evaluation of a self-microemulsifying drug delivery system of lovastatin.
Goyal U; Arora R; Aggarwal G
Acta Pharm; 2012 Nov; 62(3):357-70. PubMed ID: 23470348
[TBL] [Abstract][Full Text] [Related]
19. The high water solubility of inclusion complex of taxifolin-γ-CD prepared and characterized by the emulsion solvent evaporation and the freeze drying combination method.
Zu Y; Wu W; Zhao X; Li Y; Zhong C; Zhang Y
Int J Pharm; 2014 Dec; 477(1-2):148-58. PubMed ID: 25455767
[TBL] [Abstract][Full Text] [Related]
20. Preparation of fenofibrate dry emulsion and dry suspension using octenyl succinic anhydride starch as emulsifying agent and solid carrier.
Pongsamart K; Kleinebudde P; Puttipipatkhachorn S
Int J Pharm; 2016 Feb; 498(1-2):347-54. PubMed ID: 26707411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
